HIGHLIGHTS
- who: Ying Yang from the Nanjing Medical University, China have published the research work: MicroRNAs (miRNAs): Novel potential therapeutic targets in colorectal cancer, in the Journal: (JOURNAL)
- what: The results of this work showed that miR-145 could be efficiently delivered to colon cancer cells and exerted potent antitumor efficacy through a PLGA/PEI/HA vehicle.
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- future: There are still few studies on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.